Skip navigation

Trader Talk


Current DateTime: 05:41:02 10 Feb 2012
LinksList Documentid: 23279666
Expiration DateTime: 2/10/2012 5:42:26 AM

TRADER TALK VIDEO GALLERY

» More

Current DateTime: 05:41:02 10 Feb 2012
LinksList Documentid: 30483322
Expiration DateTime: 2/10/2012 5:42:22 AM

TRADER TALK RSS FEED

» Help

Current DateTime: 05:41:02 10 Feb 2012
LinksList Documentid: 30456179

MOST SHARED


Current DateTime: 05:41:02 10 Feb 2012
LinksList Documentid: 31330905
Expiration DateTime: 2/10/2012 5:42:45 AM

Current DateTime: 05:41:02 10 Feb 2012
LinksList Documentid: 23452000
Expiration DateTime: 2/10/2012 5:42:40 AM

Current DateTime: 05:41:03 10 Feb 2012
LinksList Documentid: 23452764
Expiration DateTime: 2/10/2012 5:42:24 AM
Trader Talk Video Gallery
CNBC's Bob Pisani and Art Cashin, of UBS, discuss the markets' lack of response to the Greek deal. Cashin asks what will...
CNBC's Bob Pisani and Art Cashin, of UBS, discuss the market drop and concerns the ECB's Draghi may not be able to help ...
CNBC's Bob Pisani and Art Cashin, of UBS, discuss a down dollar, the up euro and the reasons behind the mini rally. Peop...
CNBC's Jim Cramer, David Faber and Bob Pisani discuss the planned $18 million IPO of Caesars Entertainment. Cramer call...
CNBC's Bob Pisani and Art Cashin, of UBS, discuss the possibility of a Greek default. "We've seen this movie," says Cash...
CNBC's Bob Pisani and Art Cashin, of UBS, discuss the new highs on the Nasdaq and Dow, and the jobs number surprise. It ...
CNBC's Bob Pisani and Art Cashin, of UBS, discuss what happened to the global panic. We're doing alright, here, says Cas...
CNBC's Bob Pisani and Art Cashin, of UBS, discuss the consumer confidence numbers, the Case Shiller home price data's im...

Nanotechnology: What About Investing In It?

Published: Friday, 8 Feb 2008 | 2:24 PM ET
Text Size
By: Bob Pisani
Reporter

One of the most fascinating things to watch as a Wall Street reporter is the emergence of new technologies, and attempts to fund them. Biotech was the big one a decade ago, but now there are others: robotics, genetics, artificial intelligence, and now nanotechnology.

These technologies can and will be enabling--that is, they will assist companies to improve existing products and offer (startlingly) new products in the near future, but they will also likely be disruptive of many business plans.

A new research firm started up last week. iNano Capital Advisors is a registered investment advisor in Florida focusing exclusively on nanotechnology. Nanotechnology attempts to manipulate structures at the atomic level, and it has the potential to change whole industries. A nanometer is a billionth of a meter, about the size of six carbon atoms in a row.

The firm is run by Arthur Pacheco, a former president of the Securities Traders Association with a long history in the securities industry. The firm is partnering with research institutes and universities like the Smalley Institute at Rice University, which is the oldest and most respected research institute in the nanotech field, as well as the Alliance for Nanohealth, which is a research partnership of eight medical centers and colleges that do research and development.

But iNano wants to be more than just an institutional research firm. They want to nurture nanotech firms and expose them to the investment community.

They will produce research on a universe of about 200 stocks that will be directly impacted by developments in nanotchnology. The research will discuss stocks as diverse as Kimberly Clark[KMB  Loading...      ()   ] (who are interested in developing better fibers) to medical technology companies (nanocoatings for stents to make sure they are not rejected or to decrease the possibility of infection) to our parent, General Electric [GE  Loading...      ()   ] , who are making a large investment in R&D for nanotech.

What about investing in nanotech? Two problems:

1) right now, it's difficult to play nanotech directly, and

2) the science is extremely complicated and involves a lot of cross-disciplinary work. This has led a lot of investors to get discouraged by the sheer complexity of the business.

That's a mistake. This technology will--along with artificial intelligence and the advances in genetics--change the world.

But all ventures begin modestly. iNano just initiated coverage on their first pure-play nanotech investment, Harris and Harris Group [TINY  Loading...      ()   ] with a buy recommendation. Here is a link to the report.

I'll keep an eye on them, and other companies with their eye on these disruptive technologies.



Questions?  Comments? 

© 2012 CNBC, Inc. All Rights Reserved

CNBC HIGHLIGHTS

  • How much did the Facebook founder pay for other shareholders' voting rights? Not a heck of a lot, says the NY Times.
  • Here’s a look at Westminster Kennel Club’s most successful breeds and how much they cost.
  • The oft-mentioned jobs "miracle" in European economic powerhouse Germany has a dark side that's largely escaped comment.
  • Job Interview
  • When looking for that next career move,  workers need to look at the differences between a start-up and a public firm.
  • After enduring the recession, many Baby Boomers say money isn’t the most important thing they hope to leave to their kids.
  • The ‘Fast Money’ traders weigh in on fashion related stocks from apparel to footwear to accessories and fragrances.

Current DateTime: 05:41:02 10 Feb 2012
LinksList Documentid: 23279666
Expiration DateTime: 2/10/2012 5:42:26 AM


Current DateTime: 05:18:53 10 Feb 2012
LinksList Documentid: 29778428

Current DateTime: 04:15:35 10 Feb 2012
LinksList Documentid: 29779196

Current DateTime: 04:15:35 10 Feb 2012
LinksList Documentid: 29779197

Current DateTime: 04:15:35 10 Feb 2012
LinksList Documentid: 29779199
CNBCCNBC
About CNBC  |  Site Map  |  Video Reprints   |  Advertise  |  Help  |  Contact
Privacy Policy  |     |  Terms of Service  |  Independent Programming Report
  Data is a real-time snapshot  *Data is delayed at least 15 minutes
Global Business and Financial News, Stock Quotes, and Market Data and Analysis

© 2012 CNBC LLC.  All Rights Reserved.
A Division of NBCUniversal
Thomson ReutersThomson Reuters